Medications

Sanofi sues Eli Lilly for patent infringement

French pharmaceutical giant Sanofi has said it is suing US rival Eli Lilly in an American court for infringing four patents relating to its diabetes treatments.

Health

Horsemeat linked to new food scandal seized in Belgium

Belgium health authorities on Friday reported the seizure of 16.8 tonnes of horsemeat, part of it linked to a fresh food scandal in France involving meat not supposed to wind up on people's plates.

Medications

Sanofi looking at 1-2 bn euros of acquisitions per year

French pharmaceutical group Sanofi is looking to make annual acquisitions of up to two billion euros to boost its priority sectors, managing director Chris Viehbacher told Monday's Le Figaro newspaper.

Diabetes

No increased cancer risk with glargine versus human insulin

(HealthDay)—There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn (NPH) insulin, according to a study ...

Medications

Sanofi warns on '13 profit as Q2 earns slump (Update)

Competition from generic drugs continued to hammer French pharmaceutical group Sanofi in the second quarter, the company said Thursday, warning that its full-year earnings could be twice as bad as previous guidance.

page 11 from 13